ctDNA responds to neoadjuvant treatment in locally advanced rectal cancer
ctDNA is responding to neoadjuvant therapy and liquid biopsy is easily integrated into a daily routine. As part of translational research this protocol leaves room for further investigations.
Authors
- Florian Bürtin (ORCID: https://orcid.org/0000-0001-9927-1852)
- Bernd Frerker (ORCID: https://orcid.org/0009-0009-1436-6592)
- Guido Hildebrandt (ORCID: https://orcid.org/0000-0002-0498-2692)
- Michael Förster (ORCID: https://orcid.org/0000-0001-9927-5124)
- Sebastian Hinz (ORCID: https://orcid.org/0000-0001-9350-9196)
- Felix Bock
- Liema Elias
Institutions
- Christian-Albrechts-Universität zu Kiel (DE)
- University of Rostock (DE)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2024-09-22
- DOI
- https://doi.org/10.1007/s00432-024-05944-7
- Citations
- 1
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.29
Funders
- Deutsche Forschungsgemeinschaft